Age-dependent neurobehavioral plasticity following forebrain dopamine depletions

Developmental Neuroscience

Volumn 20, Issue 2-3, 1998, Pages 164-179

  Bruno, John P ^a   Sandstrom, Michael I ^a   Arnold, H Moore ^a   Nelson, Christopher L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acetylcholine; c fos; D1 receptor; D2 receptor; Dopamine; GABA; GAD65; Motor behavior; Striatum

Indexed keywords

ACETYLCHOLINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMATE DECARBOXYLASE; MESSENGER RNA;

ACETYLCHOLINE RELEASE; AGING; ARTICLE; BEHAVIOR; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; FOREBRAIN; GENE INDUCTION; INTERNEURON; LOCOMOTION; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION;

AGING; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; NEURONAL PLASTICITY; PROSENCEPHALON; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 0031827749     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017311     Document Type: Article

References (76)

1. Abrous DN, Rivet JM, Le Moal M, Herman JP: Similar post-lesion receptor readjustments following the unilateral 6-hydroxydopamine lesion of the dopaminergic mesotelencephalic system in neonatal and adult rats. Brain Res 1990;526:195-202.
2. Ariano MA: Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway. Brain Res 1988;443:204-214.
3. Baez LA, Eskridge NK, Schein R: Postnatal development of dopaminergic and cholinergic catalepsy in the rat. Eur J Pharmacol 1976;36: 155-162.
4. Bertorelli R, Consolo S: D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J Neurochem 1990;54:2145-2148.
5. Breese GR, Traylor TD: Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration on catecholamine neurons. J Pharmacol Exp Ther 1970;174:413-420.
6. Breese GR, Baumesiter AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA: Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther 1984;231: 343-354.
7. Breese GR, Napier TC, Mueller RA: Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at different ages: Functional supersensitivity of D1 dopamine receptors in neonatally lesioned rats. J Pharmacol Exp Ther 1985;234:447-455.
8. Breese GR, Criswell HE, Johnson KB, O'Callaghan JP, Duncan GE, Jensen KF, Simson PE, Mueller RA: Neonatal destruction of dopaminergic neurons. Neurotoxicology 1994;15:149-160.
9. Bruno JP: Development of drinking behavior in preweanling rats. J Comp Physiol Psychol 1981;95:1016-1027.
10. Bruno JP, Snyder AM, Stricker EM: Effects of dopamine-depleted brain lesions on suckling and weaning in rats. Behav Neurosci 1984;98: 156-161.
11. Bruno JP, Stricker EM, Zigmond MJ: Rats given dopamine-depleted brain lesions as neonates are subsensitive to dopaminergic antagonists as adults. Behav Neurosci 1985;99:771-775.
12. Bruno JP, Jackson D, Zigmond MJ, Stricker EM: Effect of dopamine-depleted brain lesions in rat pups: Role of striatal serotonergic neurons in behavior. Behav Neurosci 1987;101: 806-811.
13. Bruno JP, Moore HM, Stuckman S, Johnson B, Sarter M: Repeated microdialysis sampling as a valid technique to study cortical and striatal acetylcholine efflux. Curr Separations 1994;13: 2-5.
14. Bruno JP, Byrnes EM, Johnson BJ: Independent mediation of sensorimotor function by striatal D1 and D2 receptors in rats depleted of dopamine as neonates. Psychopharmacology 1995;122:85-94.
15. Bullit E: Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J Comp Neurol 1990; 296:517-530.
16. Byrnes EM, Reilly A, Bruno JP: Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux. Synapse 1997;26: 254-268.
17. Damsma G, Tham C. Robertson GS, Fibiger HC: Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. Eur J Pharmacol 1990;186:335-340.
18. Damsma G, Robertson GS, Tham C, Fibiger HC: Dopaminergic regulation of striatal acetylcholine release: Importance of D1 and N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 1991;259:1064-1072.
19. DeBoer P, Abercrombie ED: Physiological release of striatal acetylcholine in vivo: Modulation by D1 and D2 dopamine receptor subtypes. J Pharmacol Exp Ther 1996;277:775-785.
20. DeBoer P, Heeringa MJ, Abercrombie ED: Spontaneous release of acetylcholine in striaturn is preferentially regulated by inhibitory dopamine D2 receptors. Eur J Pharmacol 1996;317:257-262.
21. Di Chiara G, Morelli M: Dopamine-acetylcholine-glutamate interactions in the striatum: A working hypothesis; in Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds): Advances in Neurology. New York, Raven Press, 1993, vol 60.
22. Duncan GE, Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR: Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J Pharmacol Exp Ther 1987;243:1027-1034.
23. Feldblum S, Erlander MG, Tobin AJ: Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J Neurosci Res 1993;34:689-706.
24. Ferre S, O'Connor WT, Fuxe K, Ungerstedt U: The striatopallidal neuron: A main locus for adenosine-dopamine interactions in the brain. J Neurosci 1993;13:5402-5406.
25. Floran B, Aceves J, Sierra A, Martinez-Fong D: Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci Lett 1990;116:136-140.
26. Gale K, Casu M: Functional regulation of GABA turnover and GABA receptors in the nigrostriatal system: Interactions with dopamine; in Okada Y, Robers E (eds): GABA Research: From Brain to Bacteria. Amsterdam, Excerpta Medica, 1982, pp 232-245.
27. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR: D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990;250:1429-1432.
28. Gerfen CR: The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 1992;15: 285-320.
29. Gerfen CR, Keefe K, Gauda EB: D1 and D2 dopamine receptor function in the striatum: Coactivation of D1-and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J Neurosci 1995;15: 8167-8176.
30. Hall WG: What we know and don't know about the development of independent ingestion in rats. Appetite 1985;6:333-356.
31. Heffner TG, Zigmond MJ, Stricker EM: Effects of dopaminergic agonists and antagonists on feeding in intact and 6-hydroxydopamine-treated rats. J Pharmacol Exp Ther 1977;201: 386-399.
32. Hornykiewicz O: Brain dopamine in Parkinson's disease and other neurological disturbances; in Horn AS, Korf J, Westerink BHC (eds): The Neurobiology of Dopamine. New York, Academic Press, 1963, pp 633-654.
33. Hooper ML, Chiasson BJ, Robertson HA: Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of FOS and produces a behavioral effect. Neuroscience 1994;63:917-924.
34. Hunt SP, Pini A, Evan G: Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987;328:632-634.
35. Imperato A, Di Chiara G: Effects of locally applied D1 and D2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 1988;156:385-394.
36. Jackson D, Zigmond MJ: Regulation of striatal acetylcholine release by dopamine after nigrostriatal bundle injury. Ann NY Acad Sci 1990; 604:606.
37. Johnson BJ, Bruno JP: D1 and D2 receptor mediation of sensorimotor and ingestive behavior in rats depleted of dopamine during development. Behav Brain Res 1992;47:49-58.
38. Johnson BJ, Bruno JP: Dopaminergic modulation of striatal acetylcholine release in rats depleted of dopamine as neonates. Neuropharmacology 1995;34:191-203.
39. Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR: Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: Behavioral effects and induction of c-fos-like immunoreactivity. J Pharmacol Exp Ther 1992;262:855-865.
40. Joyce JN, Frohna PA, Neal-Beliveau BS: Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci Biobehav Rev 1996;20:453-486.
41. Kaufman DL, Houser CR, Tobin AJ: Two forms of the GABA synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions. J Neurochem 1991;56:720-723.
42. Kennard MA: Age and other factors in motor recovery from precentral lesions in monkeys. Am J Physiol 1936;115:138-146.
43. Kinnard J, Arnold HM, Rivera M, Frost F, Bruno JP: Dissociations between motoric activity and the D2 modulation of striatopallidal GABA release. Soc Neurosci Abstr 1997;23: 2332.
44. Laprade N, Soghomonian JJ: Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striaturn. Mol Brain Res 1995;34:65-74.
45. Lindefors E, Brodin U, Tossman J, Segovia J, Ungerstedt U: Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Exp Brain Res 1989; 74:527-534.
46. Marshall JF: Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control. Brain Res 1979;177:398-411.
47. Mercugliano M, Soghomonian JJ, Qin Y, Nguyen HQ, Feldblum S, Erlander MG, Tobin A, Chesselet MF: Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases in the basal ganglia of the rat. J Comp Neurol 1992;318:245-254.
48. Morelli M, Cozzolino A, Pinna A, Fennu S, Carta A, Di Chiara G: L-Dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors. Brain Res 1993;623:334-336.
49. Morelli M, Fenu S, Cozzolino A, Carta A, Di Chiara G: Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine lesioned rats but does not influence D2 mediated responses. Neuroscience 1993;53:673-678.
50. Neal BS, Joyce JN: Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors. Synapse 1992;11:35-46.
51. Paul ML, Graybiel AM, David J-C, Robertson HA: D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J Neurosci 1992;12:3729-3742.
52. Potter BM, Bruno JP: Food intake of rats depleted of dopamine as neonates is impaired by inhibition of catecholamine biosynthesis. Neurosci Lett 1989;107:295-300.
53. Potter BM, Bruno JP: Infant rats depleted of brain dopamine as neonates exhibit normal independent ingestion. Dev Psychobiol 1991; 24:65-79.
54. Roberts DC, Koob GF: Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav 1982;17:901-910.
55. Robertson GS, Vincent SR, Fibiger HC: D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 1992;49:285-296.
56. Robinson TE, Whishaw IQ: Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats. Brain Res 1988; 450:209-224.
57. Rogers DC, Dunnett SB: Hypersensitivity to α-methyl-p-tyrosine suggests that behavioural recovery of rats receiving neonatal 6-OHDA lesions is mediated by residual catecholamine neurones. Neurosci Lett 1989;102:108-113.
58. Rogers DC, Martel FL, Dunnett SB: Nigral grafts in neonatal rats protect from aphagia induced by subsequent adult 6-OHDA lesions: The importance of striatal location. Exp Brain Res 1990;80:172-181.
59. Sandstrom MI, Bruno JP, Soghomonian JJ: Expression of c-fos mRNA in striatum of rats depleted of dopamine as neonates. Soc Neurosci Abstr 1996;22:235.
60. Sandstrom MI, Sarter M, Bruno JP: Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates. Dev Brain Res 1996;96: 148-158.
61. Sandstrom MI, Bruno JP: Sensitivity to the motoric effects of a dopamine receptor antagonist differs as a function of age at the time of the dopamine depletion. Dev Psychobiol 1997; 30:293-300.
62. Sandstrom MI, Bruno JP: Neurobehavioral functions of residual striatal dopamine in rats treated with 6-hydroxydopamine as weanlings vs. as adults. Soc Neurosci Abstr 1997;23:190.
63. Schallert T, Petrie BF, Whishaw IQ: Neonatal dopamine depletion: Spared and unspared sensorimotor and attentional disorders and effects of further depletion in adulthood. Psychobiology 1989;17:386-396.
64. Sivam SP, Breese GR, Krause JE, Celeste NT, Mueller RA, Hong JS: Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J Neurochem 1987;49:1623-1633.
65. Sivam SP, Krause JE, Breese GR, Hong JS: Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia. J Neurochem 1991;56:1499-1508.
66. Smith DA, Bolam JP: The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 1990;13:259-273.
67. Soghomonian JJ: Effects of neonatal 6-hydroxydopamine injections on glutamate-decarboxylase, preproenkephalin, and dopamine D2 receptor mRNAs in the adult rat striatum. Brain Res 1993;621:249-263.
68. Soghomonian JJ: Differential regulation of GAD67 and PPE gene expression in the rat striatum. Brain Res 1994;640:146-153.
69. Soghomonian JJ, Laprade N, Sandstrom MI, Bruno JP: Chronic but not acute administration of SKF-38393 increases GAD65 mRNA levels in the striatum of rats depleted of dopamine as neonates. Soc Neurosci Abstr 1997;23: 747.
70. Solimena M, Aggujaro D, Muntzel C, Dirkx R, Butler M, DeCamilli P, Hayday A: Association of GAD65, but not of GAD67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N-terminal region. Proc Natl Acad SCi USA 1993;90:3073-3077.
71. Stricker EM, Zigmond MJ: Brain monoamines, homeostasis, and adaptive behavior; in Bloom FE (ed): Handbook of Physiology. Section 1. The Nervous System; vol 4: Intrinsic Regulatory Processes of the Brain. Bethesda, American Physiological Society, 1986, pp 677-700.
72. Wang JQ, McGinty JF: The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: Regulation of D1/D2 interactions by muscarinic receptors. J Pharmacol Exp Ther 1997; 281:972-982.
73. Weihmuller FB, Bruno JP: Age-dependent plasticity in the dopaminergic control of sensorimotor development. Behav Brain Res 1989; 35:95-109.
74. Weihmuller FB, Bruno JP: Drinking behavior and motor function in rat pups depleted of brain dopamine during development. Dev Psychol Biol 1989;22/2:101-114.
75. Weinberger DR, Berman KF, Chase TN: Mesocortical dopaminergic function and human cognition. Ann NY Acad Sci 1988;537:330-338.
76. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM: Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications. Trends Neurosci 1990;13:290-296.